Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 2,095 | 1,754 | 1,797 | 2,522 | 1,902 |
| Operating Income | -2,095 | -1,754 | -1,797 | -2,522 | -1,902 |
| Other Income | 44 | 28 | -445 | -5,867 | -779 |
| Pre-tax Income | -2,051 | -1,726 | -2,242 | -8,390 | -2,681 |
| Net Income Continuous | -2,051 | -1,726 | -2,242 | -8,390 | -2,681 |
| Net Income | $-2,051 | $-1,726 | $-2,242 | $-8,390 | $-2,681 |
| EPS Basic Total Ops | -25.34 | 566.01 | -160.60 | -985.08 | -472.49 |
| EPS Basic Continuous Ops | -25.32 | 543.32 | -160.11 | -984.14 | -473.24 |
| EPS Diluted Total Ops | -25.34 | 566.01 | -160.60 | -985.08 | -472.49 |
| EPS Diluted Continuous Ops | -25.32 | 543.32 | -160.11 | -984.14 | -473.24 |
| EPS Diluted Before Non-Recurring Items | -25.32 | -59.77 | -161.30 | N/A | N/A |
| EBITDA(a) | $-2,088 | $-1,747 | $-1,790 | $-2,515 | $-1,896 |